Thus, our results demonstrate that a significant fraction of GIST patients actually affected by a KIT–mutant tumor are missed by the state-of-the-art molecular diagnostic protocols due to the limits of the standard techniques in use. The gene discussed is KIT; the disease is neoplasm.